Shahidul Islam

Prof. Shahidul Islam

Department of Biochemistry, School of Life Sciences, University of KwaZulu-Natal (Westville Campus), Durban 4000, South Africa
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 February 2020 in Metabolic Brain Disease
Verified
Journal Article
Closed access
PDF file
VSVeronica F. Salau
Veronica F. Salau
OEOchuko Lucky Erukainure
Ochuko Lucky Erukainure
CICollins U. Ibeji
Collins U. Ibeji
TOTosin A. Olasehinde
Tosin A. Olasehinde
NKNeil A. Koorbanally
Neil A. Koorbanally
Shahidul IslamShahidul Islam
Shahidul Islam

1 January 2013 in Journal of Diabetes Research
Verified
Journal Article
Open access
PDF file
Shahidul IslamShahidul Islam
Shahidul Islam
Diabetic or peripheral diabetic neuropathy (PDN) is one of the major complications among some other diabetic complications such as diabetic nephropathy, diabetic retinopathy, and diabetic cardiomyopathy. The use of animal models in the research of diabetes and diabetic complications is very common when rats and mice are most commonly used for many reasons. A numbers of animal models of diabetic and PDN have been developed in the last several decades such as streptozotocin-induced diabetic rat models, conventional or genetically modified or high-fat diet-fed C57BL/Ks (db/db) mice models, streptozotocin-induced C57BL6/J and ddY mice models, Chinese hamster neuropathic model, rhesus monkey PDN model, spontaneously diabetic WBN/Kob rat model, L-fucose-induced neropathic rat model, partial sciatic nerve ligated rat model, nonobese diabetic (NOD) mice model, spontaneously induced Ins2 Akita mice model, leptin-deficient (ob/ob) mice model, Otsuka Long-Evans Tokushima Fatty (OLETF) rat model, surgically-induced neuropathic model, and genetically modified Spontaneously Diabetic Torii (SDT) rat model, none of which are without limitations. An animal model of diabetic or PDN should mimic the all major pathogeneses of human diabetic neuropathy. Hence, this review comparatively evaluates the animal models of diabetic and PDN which are developed since 1960s with their advantages and disadvantages to help diabetic research groups in order to more accurately choose an appropriate model to meet their specific research objectives.

18 July 2012
Verified
Book Chapter
Closed access
PDF file
Shahidul IslamShahidul Islam
Shahidul Islam
RWRachel Dorothy Wilson
Rachel Dorothy Wilson

16 June 2019 in Critical Reviews in Food Science and Nutrition
Verified
Journal Article
Closed access
BWBettina Karin Wölnerhanssen
Bettina Karin Wölnerhanssen
AMAnne Christin Meyer-Gerspach
Anne Christin Meyer-Gerspach
CBChristoph Beglinger
Christoph Beglinger
Shahidul IslamShahidul Islam
Shahidul Islam
Xylitol and erythritol are widely used in a variety of food and oral care products as sugar substitutes. Although a number of studies have been conducted on the health benefits of xylitol since the 1960s, erythritol only attracted the attention of researchers during the early 1990s. Historically, researchers mainly focused on the effects of xylitol and other sugar alcohols on oral and dental healthcare while the anti-diabetic or antihyperglycemic effects have only been revealed recently. Though a few reviews have been published on the health benefits of sugar alcohols in the last few decades, none of them closely evaluated the antihyperglycemic potential and underlying mechanisms, particularly with a focus on xylitol and erythritol. The current review thoroughly analyzes the anti-diabetic and antihyperglycemic effects as well as other metabolic effects of xylitol and erythritol using articles published in PubMed since the 1960s, containing research done on experimental animals and humans. This review will help researchers ascertain the controversies surrounding sugar alcohols, investigate further beneficial effects of them as well as aid food industries in exploring the possibilities of using sugar alcohols as anti-diabetic supplements in diabetic foods and food products.

1 December 2017 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Closed access
OEOchuko Lucky Erukainure
Ochuko Lucky Erukainure
RMRamgopal Mopuri
Ramgopal Mopuri
OOOlajumoke Oyebode
Olajumoke Oyebode
NKNeil A. Koorbanally
Neil A. Koorbanally
Shahidul IslamShahidul Islam
Shahidul Islam

15 March 2021 in Journal of Food and Drug Analysis
Verified
Journal Article
Open access
PDF file
NMNontokozo Z. Msomi
Nontokozo Z. Msomi
OEOchuko L Erukainure
Ochuko L Erukainure
Shahidul IslamShahidul Islam
Shahidul Islam
The major goals in the management of diabetes are to maintain normal control of glucose metabolism and glycemia. Dietary modification is one of the most recommended treatment modalities for diabetic patients. The use of foods sweetened with sugar alcohols (also known as polyols) such as xylitol, sorbitol, mannitol, maltitol, lactitol, isomalt and erythritol, has brought an escalating interest. Since some sugar alcohols do not raise plasma glucose, as they are partially digested and metabolised. Diet composition and adequacy may be altered by replacing carbohydrates with sugar alcohols. It has been established that these polyols are appropriate sugar substitutes for a healthy lifestyle and diabetic foods. The present review focuses on the evidence supporting the use of sugar alcohols in the management of diabetes, by evaluating their physical and chemical properties, metabolism, absorption, glycemic and insulinemic control. Although documentation on the glycaemic and insulinemic response of polyols is evident that these compounds are antidiabetic, there is however a dearth in literature on the possible toxicity and/or side effects associated with their usage at normal or abusive doses. Thus, future studies should also focus on toxicity associated with their usage in order to define their safety.